These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11586265)

  • 1. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
    Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
    J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer.
    Veeramani S; Yuan TC; Chen SJ; Lin FF; Petersen JE; Shaheduzzaman S; Srivastava S; MacDonald RG; Lin MF
    Endocr Relat Cancer; 2005 Dec; 12(4):805-22. PubMed ID: 16322323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
    Meng TC; Lee MS; Lin MF
    Oncogene; 2000 May; 19(22):2664-77. PubMed ID: 10851066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
    Lin MF; DaVolio J; Garcia-Arenas R
    Cancer Res; 1992 Sep; 52(17):4600-7. PubMed ID: 1380886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
    Lin MF; Garcia-Arenas R; Kawachi M; Lin FF
    Cell Mol Biol Res; 1993; 39(8):739-50. PubMed ID: 7951413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
    Lin MF; Meng TC
    Biochem Biophys Res Commun; 1996 Sep; 226(1):206-13. PubMed ID: 8806615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
    Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF
    Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter.
    Zelivianski S; Igawa T; Lim S; Taylor R; Lin MF
    Oncogene; 2002 May; 21(23):3696-705. PubMed ID: 12032838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
    Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
    Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphotyrosine antibodies preferentially react with basal epithelial cells in the dog prostate.
    Landry F; Chapdelaine A; Bégin LR; Chevalier S
    J Urol; 1996 Jan; 155(1):386-90. PubMed ID: 7490893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of c-ErbB-2 is regulated by the cellular form of prostatic acid phosphatase in human prostate cancer cells.
    Meng TC; Lin MF
    J Biol Chem; 1998 Aug; 273(34):22096-104. PubMed ID: 9705354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C pathway is involved in regulating the secretion of prostatic acid phosphatase in human prostate cancer cells.
    Lin MF; Zhang XQ; Dean J; Lin FF
    Cell Biol Int; 2001; 25(11):1139-48. PubMed ID: 11913958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
    Lin MF; Lee MS; Garcia-Arenas R; Lin FF
    Cell Biol Int; 2000; 24(10):681-9. PubMed ID: 11023645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of coordinated molecular alterations in the development of androgen-independent prostate cancer: an in vitro model that corroborates clinical observations.
    Shi Y; Chatterjee SJ; Brands FH; Shi SR; Pootrakul L; Taylor CR; Datar R; Cote RJ
    BJU Int; 2006 Jan; 97(1):170-8. PubMed ID: 16336351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
    Nagasawa J; Mizokami A; Koshida K; Yoshida S; Naito K; Namiki M
    Int J Urol; 2006 May; 13(5):587-92. PubMed ID: 16771730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells.
    Zhang XQ; Lee MS; Zelivianski S; Lin MF
    J Biol Chem; 2001 Jan; 276(4):2544-50. PubMed ID: 11067847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer.
    Wu C; Zhang L; Bourne PA; Reeder JE; di Sant'Agnese PA; Yao JL; Na Y; Huang J
    Prostate; 2006 Aug; 66(11):1125-35. PubMed ID: 16652382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.